NGF Treatment for Patients With Neuropathic Corneal Pain
NCT05700864
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Funding of study was withdrawn
Conditions
Corneal Disease
Neuropathy
Interventions
DRUG:
Cenegermin-Bkbj
Sponsor
Tufts Medical Center
Collaborators
[object Object]